114 related articles for article (PubMed ID: 8031560)
41. Surgical treatment for limited small-cell lung cancer. The University of Toronto Lung Oncology Group experience.
Shepherd FA; Ginsberg RJ; Feld R; Evans WK; Johansen E
J Thorac Cardiovasc Surg; 1991 Mar; 101(3):385-93. PubMed ID: 1847981
[TBL] [Abstract][Full Text] [Related]
42. Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer.
van Meerbeeck JP; Kramer GW; Van Schil PE; Legrand C; Smit EF; Schramel F; Tjan-Heijnen VC; Biesma B; Debruyne C; van Zandwijk N; Splinter TA; Giaccone G;
J Natl Cancer Inst; 2007 Mar; 99(6):442-50. PubMed ID: 17374834
[TBL] [Abstract][Full Text] [Related]
43. Present views of the surgical treatment of non-small cell lung cancer.
Lacquet LK
Verh K Acad Geneeskd Belg; 1994; 56(5):473-93; discussion 493-7. PubMed ID: 7892746
[TBL] [Abstract][Full Text] [Related]
44. [Two patterns of mediastinal lymph node resection for non-small cell lung cancer of stage IIIA: survival analysis of 219 cases].
Zhang GQ; Han F; Gao SL; A DL; Pang ZL
Ai Zheng; 2007 May; 26(5):519-23. PubMed ID: 17672944
[TBL] [Abstract][Full Text] [Related]
45. [The study of peri-operative chemotherapy in stage I-IIIa NSCLC].
Liao ML; Zhou YZ; Ding JA; Ni GX; Zhao JM; Chen WH; Han BH; Shen J; Bai H; Chen ZW; Ji H; Wang HM; Zhou Z
Zhonghua Yi Xue Za Zhi; 2003 Jun; 83(11):962-6. PubMed ID: 12899797
[TBL] [Abstract][Full Text] [Related]
46. [Surgical strategy for stage III non-small cell lung cancer; a review based on our experience and the literature].
Horio H
Gan To Kagaku Ryoho; 2007 Jun; 34(6):836-40. PubMed ID: 17565243
[TBL] [Abstract][Full Text] [Related]
47. [Relatively non-curative resection for lung cancer: is this a complete resection?].
Nonaka M; Kadokura M; Yamamoto S; Kataoka D; Iyano K; Kawada T; Takaba T
Kyobu Geka; 2000 Aug; 53(9):759-62. PubMed ID: 10935403
[TBL] [Abstract][Full Text] [Related]
48. Surgical treatment of primary lung cancer with synchronous brain metastases.
Billing PS; Miller DL; Allen MS; Deschamps C; Trastek VF; Pairolero PC
J Thorac Cardiovasc Surg; 2001 Sep; 122(3):548-53. PubMed ID: 11547308
[TBL] [Abstract][Full Text] [Related]
49. Induction chemotherapy with and without recombinant human granulocyte colony-stimulating factor support in locally advanced stage IIIA/B non-small cell lung cancer.
Fischer JR; Manegold C; Bülzebruck H; Vogt-Moykopf I; Drings P
Semin Oncol; 1994 Jun; 21(3 Suppl 4):20-7. PubMed ID: 7516094
[TBL] [Abstract][Full Text] [Related]
50. Advantage of post-operative oral administration of UFT (tegafur and uracil) for completely resected p-stage I-IIIa non-small cell lung cancer (NSCLC).
Tanaka F; Miyahara R; Ohtake Y; Yanagihara K; Fukuse T; Hitomi S; Wada H
Eur J Cardiothorac Surg; 1998 Sep; 14(3):256-62; discussion 263-4. PubMed ID: 9761434
[TBL] [Abstract][Full Text] [Related]
51. Survival of patients with advanced non-small-cell lung cancer at Ubon Ratchathani Cancer Center, Thailand.
Srisam-Ang K; Podhipak A; Narksawat K; Supaattagorn P; Tipayamongkholgul M
Southeast Asian J Trop Med Public Health; 2005 Jul; 36(4):994-1006. PubMed ID: 16295558
[TBL] [Abstract][Full Text] [Related]
52. Risk factors for local recurrence after lobectomy and lymph node dissection in patients with non-small cell lung cancer: Implications for adjuvant therapy.
Isaka M; Kojima H; Takahashi S; Omae K; Ohde Y
Lung Cancer; 2018 Jan; 115():28-33. PubMed ID: 29290258
[TBL] [Abstract][Full Text] [Related]
53. Surgical outcome of stage IIIA- cN2/pN2 non-small-cell lung cancer patients in Japanese lung cancer registry study in 2004.
Yoshino I; Yoshida S; Miyaoka E; Asamura H; Nomori H; Fujii Y; Nakanishi Y; Eguchi K; Mori M; Sawabata N; Okumura M; Yokoi K;
J Thorac Oncol; 2012 May; 7(5):850-5. PubMed ID: 22481238
[TBL] [Abstract][Full Text] [Related]
54. Prognostic heterogeneity of the seventh edition of UICC Stage III gallbladder carcinoma: Which patients benefit from surgical resection?
Sakata J; Kobayashi T; Ohashi T; Hirose Y; Takano K; Takizawa K; Miura K; Ishikawa H; Toge K; Yuza K; Soma D; Ando T; Wakai T
Eur J Surg Oncol; 2017 Apr; 43(4):780-787. PubMed ID: 28132788
[TBL] [Abstract][Full Text] [Related]
55. Outcomes and prognostic factors of non-small-cell lung cancer with lymph node involvement treated with induction treatment and surgical resection.
Marulli G; Verderi E; Zuin A; Schiavon M; Battistella L; Perissinotto E; Romanello P; Favaretto AG; Pasello G; Rea F
Interact Cardiovasc Thorac Surg; 2014 Aug; 19(2):256-62; discussion 262. PubMed ID: 24824495
[TBL] [Abstract][Full Text] [Related]
56. Outcomes of patients with stage III nonsmall cell lung cancer treated with chemotherapy and radiation with and without surgery.
Caglar HB; Baldini EH; Othus M; Rabin MS; Bueno R; Sugarbaker DJ; Mentzer SJ; Jänne PA; Johnson BE; Allen AM
Cancer; 2009 Sep; 115(18):4156-66. PubMed ID: 19551884
[TBL] [Abstract][Full Text] [Related]
57. Surgical therapy for carcinoma of the lung.
Shields TW
Clin Chest Med; 1993 Mar; 14(1):121-47. PubMed ID: 8384959
[TBL] [Abstract][Full Text] [Related]
58. Extracapsular extension is a powerful prognostic factor in stage IIA-IIIA non-small cell lung cancer patients with completely resection.
Liu W; Shao Y; Guan B; Hao J; Cheng X; Ji K; Wang K
Int J Clin Exp Pathol; 2015; 8(9):11268-77. PubMed ID: 26617851
[TBL] [Abstract][Full Text] [Related]
59. [Multivariate survival analysis of 899 patients with non-small cell lung cancer after complete resection].
Wei WD; Wen ZS; Su XD; Lin P; Rong TH; Chen LK
Ai Zheng; 2007 Nov; 26(11):1231-6. PubMed ID: 17991324
[TBL] [Abstract][Full Text] [Related]
60. [Survival Analysis of 121 Stage N2-IIIa Non-small Cell Lung Cancer Patients
Treated with Surgery].
Yang H; Dai L; Li P; Shen L; Yan W; Fan M; Chen K
Zhongguo Fei Ai Za Zhi; 2015 Aug; 18(8):505-11. PubMed ID: 26302348
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
